Overview

Aphrodite Health is a US-based first female-focused psychedelic biotech company introducing psychedelic medicines to address women’s mental and physical health challenges overlooked by modern medicine. Launched by a team of all-female founders in 2021, the brand will launch a low-dose, targeted medicine to disrupt the existing antidepressant market used to treat hormone-related mood disorders in menopause, an overlooked health condition that will be impacting a billion women globally by 2025.